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iMore Positive Fluid Balance
Could Explain Lower Risk of
Contrast Nephropathy
The paper by Marenzi et al. (1) in JACC: Cardiovascular Interven-
tions on prevention of contrast-induced nephropathy (CIN) using
furosemide with matched hydration deals with a pertinent and
pervasive problem. In this randomized trial of 170 patients who
received contrast media during coronary procedures, the investi-
gators compared standard-of-care hydration using intravenous
(IV) isotonic saline with furosemide-forced diuresis and IV iso-
tonic saline infusion matched to the urine output. This interven-
tion arm was associated with a lower incidence of CIN (4.6% vs.
18% in control subjects, p  0.005). However, a crucial piece of
data missing in the study, which might confound the results, is the
patients’ net fluid balance at the end of their respective protocols.
Adequate hydration before contrast administration is considered
the cornerstone of CIN prevention, although no randomized
controlled trial has studied the benefit of hydration alone. It would
have added to the validity of the study had the patients’ weights
been mentioned before and after the protocol because that could be
a good surrogate of the patients’ net hydration status. Estimation
of the net fluid balance based just on the difference between the
cumulative IV hydration and the urine outputs shows that patients
in the furosemide-matched hydration group were perhaps much
better volume repleted than the control subjects were. Patients in
the intervention arm received cumulative IV saline volume of
3,995  1,401 ml, with infusion rates matched to the urine output
(minus the initial 250-ml IV saline bolus). This indicates an even-
to-slightly-positive net fluid balance over the duration of the
protocol. The control group, however, received a cumulative IV
saline volume of 1,742  290 ml while putting out a urine volume
of 3,117  876 ml. This clearly suggests a net negative fluid
balance of about 1.3 l. Hence, how much of the final efficacy of
furosemide-matched hydration protocol over standard saline hy-
dration in preventing CIN could be attributed to the use of
furosemide, versus to the fact that patients in the intervention arm
just happened to be much better hydrated, remains debatable.
Some of the classic studies that studied volume repletion as a
measure to prevent CIN have shown that patients who did better
tended to be in an even-to-positive fluid balance, although the
results were not always statistically significant (2,3)
The study, however, definitely forces us to question our pur-
orted definition of “adequate” isotonic saline hydration in prep-
ration for contrast administration (1.0 to 1.5 ml/kg/h for 3 to 12 h
efore the procedure and continuing for 6 to 24 h after the
rocedure, per current guidelines) (4). The control group clearly
eceived hydration that was commensurate with guidelines, yet did
ignificantly worse than the intervention “superhydrated” arm.
his could be a novel proof of concept, worth validating by futurerials, wherein an isotonic saline hydration rate of as much as 600 tml/h for a shorter duration of about 6 h (as was used in the study)
might be a better prophylactic regimen against CIN compared
with what current guidelines recommend. A shorter hydration
regimen might also be logistically easier to implement and have
implications for cost savings.
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Hydration Is Critical for Prevention
of Contrast-Induced Nephropathy
Marenzi et al. (1) recently reported the results on a single-center,
prospective, randomized, nonblinded trial to investigate the role of
combined furosemide-induced high-volume diuresis and auto-
mated matched hydration (intervention group), combined with
standard saline hydration (control group), for the prevention of
contrast-induced nephropathy (CIN) in chronic kidney disease
patients undergoing coronary procedures.
However, it is worth noting that the 2 study groups were
different with respect to the fluids infused. In the intervention
group during the 6  1 h of treatment, the volume of saline
ydration was 3,995 1,401 ml. Urine output was matched to the
nfusion rate (minus the 250-ml fluid bolus received as specified in
he protocol). The intervention group thus had a net positive fluid
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455balance. In the control group, during the 25  2-h treatment
period, the cumulative saline hydration was 1,742  290 ml.
mportantly, however, urine output during hydration in the control
roup was 3,117  876 ml. Thus, the control group had a net
egative fluid balance. The reason for this finding is not entirely
lear. It is possible that continuing the diuretics that both groups
f patients were on as outpatients caused this finding. Forty-eight
f 83 (58%) of patients in the control group were on diuretics, and
here was no protocol to stop these medications before the
ntervention. Thus, the differences in the fluid administered and
he fluid balance achieved likely influenced the results of the study
n the 2 groups.
Majumdar et al. (2) in their meta-analysis comparing furosemide-
ased intervention with saline hydration for the prevention of CIN
oncluded furosemide-based interventions to be detrimental to
aline hydration for the prevention of CIN. However, the studies
hat were analyzed did not have as rigorous a method of hydration
n the intervention arms as did the study by Marenzi et al. (1).
In light of prior randomized controlled trials, to demonstrate
enefit of furosemide-based intervention with hydration over
aline hydration alone for the prevention of CIN, it is critical to
eep both study arms equally hydrated. Failure to do so may
nfluence the results of the study. Thus, studies maintaining equal
ydration in both groups are needed to demonstrate a difference in
utcome due to the intervention.
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Reply
We appreciate the thoughtful comments of Drs. Chauhan and
Sharma on our study. We agree with them with regard to the
critical importance of generous hydration and positive fluid balance
for contrast-induced nephropathy prevention. Current guidelines
recommend administration of isotonic electrolyte solutions at an
infusion rate of 1.0 ml/kg/h or less (0.5 ml/kg/h) in case of leftventricular ejection fraction35% or New York Heart Association
functional class 2 (1). We believe that this hydration rate
represents a “safe” regimen conceived for avoiding fluid overload
and pulmonary edema rather than an “effective” patient hydration.
Indeed, a 70-ml/h hydration rate for 24 h in a 70 kg fasting patient
is the minimal fluid volume needed to avoid dehydration. By
contrast, vigorous hydration before coronary procedures is difficult
logistically and poorly tolerated, in particular in the presence of
impaired cardiac and renal function. Thus, despite general agree-
ment on hydration benefit and strong recommendation of all
guidelines, most patients are not sufficiently hydrated in routine
clinical practice.
In our study (2), saline infusion and urine output were rigor-
ously measured. However, from these data it is not possible to
extrapolate the net fluid balance, because all patients were encour-
aged to freely drink water after coronary angiography. Thus, it is
likely that the control group too had a modestly positive or, at
worst, a slightly negative fluid balance.
Although further studies are needed to elucidate the mecha-
nisms of the innovative preventive treatment described in our
report, it is unlikely that its beneficial effects might be explained by
the initial 250-ml saline bolus only. We believe that simultaneous
high urine-flow rate resulting from furosemide administration
together with dehydration prevention obtained by exactly match-
ing saline infusion might have played an important role in the
results observed in the treated patients. Indeed, preclinical studies
demonstrated that prolonged contact time of contrast with the
tubular epithelial cells is associated with a greater tubular damage,
as indicated by biomarkers (3), and that high urine-flow rates flush
the renal tubules and lower contrast concentration in tubular fluid.
This accelerates contrast excretion, thus reducing the exposure
time of tubular cells. Therefore, the high urine-flow rate achievable
with this innovative treatment might lower contrast concentration
and viscosity and accelerate contrast excretion, thus reducing the
exposure time of tubular cells to its toxicity (4).
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